Article
N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through…
Journal of Hepatocellular Carcinoma · 2023 · Wei H, Huang L, Lu Q, Huang Z, Huang Y, Xu Z, Li W, Pu J
Key facts
| Title | N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling |
|---|---|
| First author | Wei H, Huang L, Lu Q, Huang Z, Huang Y, Xu Z, Li W, Pu J |
| Journal | Journal of Hepatocellular Carcinoma |
| Published | Nov 6, 2023 |
| DOI | 10.2147/JHC.S433070 |
| Devices mentioned | 020378 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1